MedTrace Logo

Bacteriophage Therapy of Difficult-to-treat Infections

NCT05498363 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-08-12

No results posted yet for this study

Summary

A retrospective, observational analysis of the first one hundred consecutive cases of bacteriophage therapy of difficult-to-treat infections, facilitated by a Belgian consortium.

Conditions

Interventions

BIOLOGICAL

Bacteriophage therapy

Difficult-to-treat bacterial infections were treated with bacteriophages (selected from a collection of 25 individual bacteriophages and 6 bacteriophage cocktails), which were shown to target the patient's infecting bacterial strain (in vitro)

Sponsors & Collaborators

  • Queen Astrid Military Hospital

    lead OTHER

Principal Investigators

  • Sarah Djebara, MD · Queen Astrid Military Hospital

Eligibility

Min Age
1 Month
Max Age
91 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05498363 on ClinicalTrials.gov